Risperidone Therapy
Risperidone Therapy is a pharmacotherapeutic intervention within the class of antipsychotic treatments that employs the atypical antipsychotic risperidone as its primary agent to modulate dopaminergic and serotonergic neurotransmission for the management of psychotic disorders.
3K
Publications
172.3K
Citations
10.5K
Authors
2.7K
Institutions
Publications per year
2017–2026
347
3K
Risperidone in Children with Autism and Serious Behavioral Problems
James T. McCracken, James J. McGough, Bhavik Shah et al. · New England Journal of Medicine · 2002 · 1.6K citations · Full text
Risperidone in the treatment of schizophrenia
Stephen R. Marder, Richard C. Meibach · American Journal of Psychiatry · 1994 · 1.2K citations
Patrick D. McGorry, Alison R. Yung, Lisa Phillips et al. · Archives of General Psychiatry · 2002 · 1.1K citations · Full text
1–5 of 3K
10.5K
32
h-index
30
h-index
29
h-index
28
h-index
28
h-index
1–5 of 10.5K
2.7K

Janssen (Belgium)
Beerse, Belgium
49 h-index
271 publications
38.6K citations
Janssen (United States)
Hopewell, United States
39 h-index
254 publications
13.9K citations
Johnson & Johnson (United States)
New Brunswick, United States
39 h-index
152 publications
13.5K citations
Eli Lilly (United States)
Indianapolis, United States
36 h-index
194 publications
16.6K citations

Tehran University of Medical Sciences
Tehran, Iran
32 h-index
281 publications
15.3K citations
Zucker Hillside Hospital
New York, United States
32 h-index
113 publications
7.8K citations

University of Toronto
Toronto, Canada
31 h-index
125 publications
10.6K citations
University of California, Los Angeles
Los Angeles, United States
31 h-index
82 publications
8.1K citations
1–8 of 2.7K
175 publications · 15.8K citations
75
h-index
85 publications · 18.7K citations
68
h-index
122 publications · 9.1K citations
52
h-index
Repository · 193 publications · 9.5K citations
51
h-index
JCAP · 91 publications · 4.8K citations
43
h-index
1–5